Johannesburg, South Africa
Ascendis Health is a health and wellness company founded in 2008 and listed in the healthcare sector of the JSE in November 2013. The company has made significant strides in international expansion, acquiring four businesses in Europe: Farmalider in Spain (2015), Remedica in Cyprus (2016), Scitec in Hungary (2016), and Sunwave Pharma in Romania (2017), enabling its global reach with products sold in over 120 countries.
Ascendis Health has outlined a comprehensive three-pillar strategic focus: Stabilise, Optimise, and Grow. The company aims to address its debt constraints by restructuring and introducing new capital (Post-IPO Equity investment at 01 May 2016 by Ata Capital). It also plans to align its operating model with its portfolio strategy, focus on efficiency and margin management, and create incentivization programs within its Business Units. Furthermore, Ascendis Health aims to maximize value and grow its platforms through a deleveraging strategy and the deployment of capital for sustainable growth.
Despite facing challenges such as high debt and limited operational flexibility, Ascendis Health's robust international presence and strategic initiatives demonstrate potential for growth and stability, positioning the company as an appealing investment opportunity in the healthcare industry, particularly for venture capitalists seeking exposure to the global health and wellness market.
